<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0645">
 <label>129</label>
 <element-citation publication-type="journal" id="sbref0645">
  <person-group person-group-type="author">
   <name>
    <surname>Lok</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Pan</surname>
    <given-names>C.Q.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Trinh</surname>
    <given-names>H.N.</given-names>
   </name>
   <name>
    <surname>Fessel</surname>
    <given-names>W.J.</given-names>
   </name>
   <name>
    <surname>Rodell</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B</article-title>
  <source>J. Hepatol.</source>
  <volume>65</volume>
  <issue>3</issue>
  <year>2016</year>
  <fpage>509</fpage>
  <lpage>516</lpage>
  <pub-id pub-id-type="pmid">27210427</pub-id>
 </element-citation>
</ref>
